Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W Barton

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Pediatrics|July 1, 1988
Treatable dystonia presenting as spastic cerebral palsyJ K Fink, M R Filling-Katz, N W Barton, et al.
Blood Cells, Molecules & Diseases|October 24, 2000
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher diseaseG Altarescu, R Schiffmann, C C Parker, et al.
Neurology|January 1, 1992
Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome)J J Higgins, M C Patterson, N M Papadopoulos, et al.
Neurology|October 1, 1989
Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variationJ K Fink, P Ravin, C E Argoff, et al.
Radiology|August 1, 1992
Gaucher disease: abdominal MR imaging findings in 46 patientsS C Hill, B M Damaska, A Ling, et al.
Neurology|June 20, 1998
Quantitative analysis of cerebral vasculopathy in patients with Fabry diseaseK E Crutchfield, N J Patronas, J M Dambrosia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 17, 1998
Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C diseaseG Tedeschi, S Bonavita, N W Barton, et al.
The Journal of Pediatrics|April 11, 2001
The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's diseaseG Altarescu, S Hill, E Wiggs, et al.
American Journal of Human Genetics|October 1, 1993
Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patientsM Horowitz, G Tzuri, N Eyal, et al.
Pediatrics|May 19, 1998
Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher diseaseR O Brady, G J Murray, K L Oliver, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Pediatrics|July 1, 1988
Treatable dystonia presenting as spastic cerebral palsyJ K Fink, M R Filling-Katz, N W Barton, et al.
Blood Cells, Molecules & Diseases|October 24, 2000
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher diseaseG Altarescu, R Schiffmann, C C Parker, et al.
Neurology|January 1, 1992
Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome)J J Higgins, M C Patterson, N M Papadopoulos, et al.
Neurology|October 1, 1989
Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variationJ K Fink, P Ravin, C E Argoff, et al.
Radiology|August 1, 1992
Gaucher disease: abdominal MR imaging findings in 46 patientsS C Hill, B M Damaska, A Ling, et al.
Neurology|June 20, 1998
Quantitative analysis of cerebral vasculopathy in patients with Fabry diseaseK E Crutchfield, N J Patronas, J M Dambrosia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 17, 1998
Proton magnetic resonance spectroscopic imaging in the clinical evaluation of patients with Niemann-Pick type C diseaseG Tedeschi, S Bonavita, N W Barton, et al.
The Journal of Pediatrics|April 11, 2001
The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's diseaseG Altarescu, S Hill, E Wiggs, et al.
American Journal of Human Genetics|October 1, 1993
Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patientsM Horowitz, G Tzuri, N Eyal, et al.
Pediatrics|May 19, 1998
Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher diseaseR O Brady, G J Murray, K L Oliver, et al.
Pageof 7